Ekso Bionics Statistics Share Statistics Ekso Bionics has 2.61M
shares outstanding. The number of shares has increased by 8.85%
in one year.
Shares Outstanding 2.61M Shares Change (YoY) 8.85% Shares Change (QoQ) 8.82% Owned by Institutions (%) 2.6% Shares Floating 2.24M Failed to Deliver (FTD) Shares 556 FTD / Avg. Volume 0.68%
Short Selling Information The latest short interest is 116.51K, so 4.92% of the outstanding
shares have been sold short.
Short Interest 116.51K Short % of Shares Out 4.92% Short % of Float 5.02% Short Ratio (days to cover) 2.63
Valuation Ratios The PE ratio is -16.28 and the forward
PE ratio is -6.49.
Ekso Bionics's PEG ratio is
0.33.
PE Ratio -16.28 Forward PE -6.49 PS Ratio 10.29 Forward PS 0.6 PB Ratio 14.52 P/FCF Ratio -18.67 PEG Ratio 0.33
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Ekso Bionics.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 2.5,
with a Debt / Equity ratio of 0.47.
Current Ratio 2.5 Quick Ratio 1.89 Debt / Equity 0.47 Debt / EBITDA -0.63 Debt / FCF -0.61 Interest Coverage -38.88
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $293.85K Profits Per Employee $-185.74K Employee Count 61 Asset Turnover 0.67 Inventory Turnover 1.84
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -64.1% in the
last 52 weeks. The beta is 1.11, so Ekso Bionics's
price volatility has been higher than the market average.
Beta 1.11 52-Week Price Change -64.1% 50-Day Moving Average 3.94 200-Day Moving Average 5.91 Relative Strength Index (RSI) 75.09 Average Volume (20 Days) 82,095
Income Statement In the last 12 months, Ekso Bionics had revenue of 17.93M
and earned -11.33M
in profits. Earnings per share was -0.56.
Revenue 17.93M Gross Profit 9.51M Operating Income -10.46M Net Income -11.33M EBITDA -9.45M EBIT -11.06M Earnings Per Share (EPS) -0.56
Full Income Statement Balance Sheet The company has 6.49M in cash and 5.98M in
debt, giving a net cash position of 510K.
Cash & Cash Equivalents 6.49M Total Debt 5.98M Net Cash 510K Retained Earnings -250.47M Total Assets 23.17M Working Capital 9.26M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -9.85M
and capital expenditures -37K, giving a free cash flow of -9.88M.
Operating Cash Flow -9.85M Capital Expenditures -37K Free Cash Flow -9.88M FCF Per Share -0.49
Full Cash Flow Statement Margins Gross margin is 53.06%, with operating and profit margins of -58.35% and -63.21%.
Gross Margin 53.06% Operating Margin -58.35% Pretax Margin -63.21% Profit Margin -63.21% EBITDA Margin -52.74% EBIT Margin -58.35% FCF Margin -55.14%
Dividends & Yields EKSO does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for EKSO is $34.75,
which is 520.5% higher than the current price. The consensus rating is "Buy".
Price Target $34.75 Price Target Difference 520.5% Analyst Consensus Buy Analyst Count 2
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Jun 2, 2025. It was a
backward
split with a ratio of 1:15.
Last Split Date Jun 2, 2025 Split Type backward Split Ratio 1:15
Scores Altman Z-Score -15.53 Piotroski F-Score 3
